BridgeMD
New treatment option for Intensive Care Unit (ICU) Admission
Official title Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU
ClinicalTrials.gov ID: NCT07481773
What this study is testing
- What it's testing
- The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Admitted to the Intensive Care Unit (ICU)
- Started on antibiotics for any suspected or confirmed infection in the preceding 72 hours (about 3 days)
- Treating doctor(s) willing to consider BV test result in antibiotic treatment decision making
You likely can't join if
- Severe immunocompromise/immunosuppression
- Congenital immunodeficiency
- HIV with CD4 \< 20
- Active chemotherapy and profound neutropenia (ANC \ 7 days;
- solid organ or stem cell transplant within preceding 6 months AND active GVHD
- Receiving high dose steroids (Pred \> 20mg/day for \> or = 2 weeks)
See the full eligibility criteria
- Admitted to the Intensive Care Unit (ICU)
- Started on antibiotics for any suspected or confirmed infection in the preceding 72 hours (about 3 days)
- Treating doctor(s) willing to consider BV test result in antibiotic treatment decision making
- Severe immunocompromise/immunosuppression
- Congenital immunodeficiency
- HIV with CD4 \< 20
- Active chemotherapy and profound neutropenia (ANC \ 7 days;
- solid organ or stem cell transplant within preceding 6 months AND active GVHD
- Receiving high dose steroids (Pred \> 20mg/day for \> or = 2 weeks)
- Advanced metastatic cancer irrespective of treatment
- Palliative intent, death imminent and inevitable within 4 weeks
- Antibiotic to be discontinued within 24h (ex. Prophylaxis)
- Active infection diagnosed and treated with antibiotics within preceding 2 weeks
- Previously included during the same hospitalization
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.